ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Creative Biostructure Presented One-stop Structural Biology Solutions at BIO International Convention 2022

By: Get News
Creative Biostructure is greatly honored to have participated in the BIO International Convention 2022 at the mid of this month in San Diego.

New York, USA – June 29, 2022 – Creative Biostructure, a biotechnology company that specializes in protein manufacturing, structure analysis and characterization to hasten drug discovery and treatment, is greatly honored to have participated in the BIO International Convention 2022 at the mid of this month in San Diego.

Held between Jun. 13-Jun. 16, this biotechnology and pharmaceutical conference was a great success. Aligned with Creative Biostructure’s strategy to partner with global researchers and scientists to solve protein structural issues, Creative Biostructure participated the BIO International Convention 2022 and presented one-stop structural biology solutions for the visiting customers, partners and researchers.

With its cutting-edge platforms, Creative Biostructure provides quick turnaround times, low pricing, and access to the most recent tools, methodologies, and knowledge for structural biology projects. To clarify the foundations of membrane protein systems, Creative Biostructure has also developed a distinctive and comprehensive membrane protein screening platform.

Currently, Creative Biostructure offers a wide range of products and services, such as X-ray crystallography, cryo-electron microscopy, NMR spectroscopy, membrane protein production, virus-like particle technology, liposome technology, exosome products, crystallization products, virus-like particles, membrane proteins, and liposome products, among others.

Along with these items, Creative Biostructure has built the target-based structural biology platform, computer-aided drug design (CADD) platform, and fragment-based drug design (FBDD) platform for speeding up the structure-based drug discovery process.

“Although it has been several days, we are still very excited. Thank you very much to those who came to the event and came to our booth. And we’re sorry if there was anything we didn’t take care of. We hope that you have learned more about Creative Biostructure, and we are also looking forward to our future cooperation.” Commented Joanna, the director in the marketing department of Creative Biostructure.

For more information about products and services at Creative Biostructure, please visit https://www.creative-biostructure.com.

Media Contact
Company Name: Creative Biostructure
Contact Person: Jerry
Email: Send Email
Phone: 1-516-855-7709
Country: United States
Website: https://www.creative-biostructure.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.